Sio Gene Therapies Inc
(SIOX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 331,069 | N/A | N/A |
| TOTAL | $331,096 | $N/A | $2 |
| Non-Current Assets | |||
| PPE Net | 16 | N/A | N/A |
| Other Non-Current Assets | 182 | 0 | 0 |
| TOTAL | $198 | $N/A | $N/A |
| Total Assets | $331,294 | $N/A | $2 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 756 | 0 | 0 |
| Accrued Expenses | 1,932 | N/A | 6 |
| Other current liabilities | 1,629 | N/A | 758 |
| TOTAL | $4,569 | $N/A | $764 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 5,000 | 0 | 5,000 |
| TOTAL | $5,000 | $N/A | $5,000 |
| Total Liabilities | $9,569 | $N/A | $5,764 |
| Shareholders' Equity | |||
| Retained earnings | -49,105 | N/A | -10,762 |
| TOTAL | $321,725 | $N/A | $-5,762 |
| Total Liabilities And Equity | $331,294 | $0 | $2 |